ADAGE Capital Partners Gp, LLC, 10% Owner at PUMA BIOTECHNOLOGY, INC. (PBYI), sold 400,000 shares at $76.91 ($31.1M) on 2017-05-25, disclosed to the SEC on 2017-05-26.
Open-market sale of $31.1M PBYI by 10% Owner. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $76.91 | 85,526 | $6.6M | 21.1% |
| 2 | $77.61 | 232,190 | $18.0M | 57.9% |
| 3 | $78.25 | 7,248 | $567K | 1.8% |
| 4 | $79.70 | 75,036 | $6.0M | 19.2% |
| Total | $77.86 avg | 400,000 | $31.1M | 100% |
| Filing → |
| GCMG | SELL | 2021-07-13 | $8.6M | — | Filing → |
| GCMG | SELL | 2021-07-13 | $1.5M | — | Filing → |
| GCMG | BUY | 2021-07-13 | $602K | — | Filing → |